Healthcare

The company has what I look for in this speculative space.

Fibocall: NPS Pharmaceuticals Real Money Pro($)

 A new spike came on Wednesday, triggering an alert.
Try these two small biotechs with no connection to the gyrations of energy markets.

2 Names Top My Watch List Real Money Pro($)

Why I'm looking at the iShares Biotech ETF and Amgen.

Take a Look at Teva Real Money Pro($)

We like new initiatives and see solid upside potential.
Has the pharmaceutical company really changed its strategy?
Investing in safer hospital stays.
A probabilistic biotech play.
Approval of malaria vaccine could provide a shot in the arm.

Baxter Is Worth a Look Real Money Pro($)

We are not ready to pull the buy trigger yet.

Columnist Conversations

Ugly end to a challenging week as stocks post around three percent declines for the opening month of 2015. Oil...
I have scaled further into a TLT short - scaling all the way up to $138.35 this morning. And I have scaled int...
Market slightly down despite the boost Amazon (AMZN) is giving the NASDAQ. Biotech also continues to be a stro...
There are a number of interesting technical signals on the weekly and daily Berkshire Hathaway (BRK/B) charts....

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.